Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 4|pp. 1959–1982
Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis
Back to articleFigure 2(2 of 8)
100%
Figure 2
Figure 2.The forest plot of HR for PFS in the weekly paclitaxel compared to 3-weeks paclitaxel regimen. HR: hazard ratio; PFS: progression-free survival.